ARCHIVES

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975